With the COVID-19 pandemic affecting people worldwide, understanding how individual risk of disease severity is reflected is critical... Nov 05
The study, Targeting ANGPTL3 with an antisense oligonucleotide in adults with dyslipidemia, will evaluate various doses of vupanorsen to inform potential future development... Nov 05
-Advertisements-